Prevalence and symptoms of incidental meningiomas: a population-based study - Top-Institutions - MDSpire

Prevalence and symptoms of incidental meningiomas: a population-based study

  • By

  • Eddie de Dios

  • Olivia Näslund

  • Mansor Choudhry

  • Marcus Berglund

  • Thomas Skoglund

  • Darko Sarovic

  • Lina Rydén

  • Silke Kern

  • Ingmar Skoog

  • Erik Thurin

  • April 3, 2025

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Radiology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Epidemiology

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Neurology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Radiology

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Neurosurgery
    • Radiation Oncology

Original Source(s)

Prevalence and symptoms of incidental meningiomas: a population-based study

  • by Eddie de Dios, Olivia Näslund, Mansor Choudhry, Marcus Berglund, Thomas Skoglund, Darko Sarovic, Lina Rydén, Silke Kern, Ingmar Skoog, Erik Thurin

  • April 3, 2025

Related Content

Pediatric meningoencephalitis in the molecular diagnostic era: epidemiological insights from 1198 suspected cases in Germany between 2016 and 2024

MimiVax and Roswell Park Open Phase 2 Trial of SurVaxM for Patients with Metastatic Neuroendocrine Tumors

Clinical study marks SurVaxM’s second phase 2 trial in a major cancer indication

  • by

  • May 7, 2026

  • 4 min
New access to intraluminal gastric pathologies: the SP da Vinci transgastric approach